Triomics is an oncology-focused generative AI company that builds AI-powered software for cancer care providers, leveraging its OncoLLM platform to automate clinical workflows such as clinical trial matching, visit preparation, and cancer registry data curation. Its AI agents reason across full patient records and integrate directly into EMRs like Epic to help cancer centers improve trial enrollment, reduce administrative burden, and streamline data abstraction.
“Triomics $22M Series B”
“Triomics $22M Series B; AI in cancer data”
“Raised $22M Series B; represents continued investment in vertical AI for healthcare”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.